Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Daily Journal Corporation is a publishing business based in the US. Daily Journal Corporation shares (DJCO) are listed on the NASDAQ and all prices are listed in US Dollars. Daily Journal Corporation employs 290 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $336.01 |
|---|---|
| 52-week range | $298.00 - $415.66 |
| 50-day moving average | $363.63 |
| 200-day moving average | $335.75 |
| Wall St. target price | N/A |
| PE ratio | 4.4394 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $81.77 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $336.01 from 2022-01-21
| 1 week (2022-01-14) | -7.44% |
|---|---|
| 1 month (2021-12-22) | -5.29% |
| 3 months (2021-10-22) | -2.14% |
| 6 months (2021-07-22) | -1.17% |
| 1 year (2021-01-22) | -1.17% |
|---|---|
| 2 years (2020-01-22) | 16.95% |
| 3 years (2019-01-22) | 56.98% |
| 5 years (2017-01-20) | 51.49% |
Valuing Daily Journal Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Daily Journal Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Daily Journal Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Daily Journal Corporation shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Daily Journal Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.5 million.
The EBITDA is a measure of a Daily Journal Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $49.4 million |
|---|---|
| Operating margin TTM | 8.06% |
| Gross profit TTM | $11.7 million |
| Return on assets TTM | 0.79% |
| Return on equity TTM | 56.97% |
| Profit margin | 228.59% |
| Book value | $184.42 |
| Market capitalisation | $501.2 million |
TTM: trailing 12 months
We're not expecting Daily Journal Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Daily Journal Corporation's shares have ranged in value from as little as $298 up to $415.66. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Daily Journal Corporation's is 0.7136. This would suggest that Daily Journal Corporation's shares are less volatile than average (for this exchange).
Daily Journal Corporation publishes newspapers and websites covering in California, Arizona, and Utah. It operates in two segments, Traditional Business and Journal Technologies. The company publishes 10 newspapers of general circulation, including Los Angeles Daily Journal, San Francisco Daily Journal, Daily Commerce, The Daily Recorder, The Inter-City Express, San Jose Post-Record, Orange County Reporter, The Daily Transcript, Business Journal, and The Record Reporter. It also provides specialized information services; and serves as an advertising and newspaper representative for commercial and public notice advertising. In addition, the company offers case management software systems and related products, including eCourt, eProsecutor, eDefender, and eProbation, which are browser-based case processing systems; eFile, a browser-based interface that allows attorneys and the general public to electronically file documents with the court; and ePayIt, a service primarily for the online payment of traffic citations. It provides its software systems and related products for courts; prosecutor and public defender offices; probation departments; and other justice agencies, including administrative law organizations, city and county governments, and bar associations to manage cases and information electronically, to interface with other justice partners, and to extend electronic services to bar members and the public in 42 states and internationally. Daily Journal Corporation was incorporated in 1987 and is based in Los Angeles, California.
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.